Abstract
ABSTRACTThe enhancer/promoter of the vitellogenin II (VTG) gene has been extensively studied as a model system of vertebrate transcriptional control. While deletion mutagenesis andin vivofootprinting identified the transcription factor (TF) binding sites governing its tissue specificity, DNase hypersensitivity- and DNA methylation studies revealed the epigenetic changes accompanying its hormone-dependent activation. Moreover, upon induction with estrogen (E2), the region flanking the estrogen-responsive element (ERE) was reported to undergo active DNA demethylation. We now show that although theVTGERE is methylated in embryonic chicken liver and in LMH/2A hepatocytes, its induction by E2was not accompanied by extensive demethylation. In contrast, E2failed to activate aVTGenhancer/promoter-controlled luciferase reporter gene methylated bySssI. Surprisingly, this inducibility difference could be traced not to the ERE, but rather to a single CpG in an E-box (CACGTG) sequence upstream of theVTGTATA box, which is unmethylatedin vivo, but methylated bySssI. We demonstrate that this E-box binds the upstream stimulating factor USF1/2. Selective methylation of the CpG within this binding site with an E-box-specific DNA methyltranferaseEco72IM was sufficient to attenuate USF1/2 bindingin vitroand abolish the hormone-induced transcription of theVTGgene in the reporter system.
Publisher
Cold Spring Harbor Laboratory
Reference73 articles.
1. Dioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liver;Scientific reports,2016
2. Recombinant Human DNA (Cytosine-5) Methyltransferase
3. Characterization of the “Mismatch Repairosome” and Its Role in the Processing of Modified Nucleosides In Vitro
4. In ovo RNAi opens new possibilities for temporal and spatial control of gene silencing during development of the vertebrate nervous system;J RNAi Gene Silencing,2006
5. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas;Cancer research,1986